Page last updated: 2024-10-22

altretamine and Liver Neoplasms

altretamine has been researched along with Liver Neoplasms in 3 studies

Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research Excerpts

ExcerptRelevanceReference
" Pharmacokinetic studies (100-500 mg m-2) indicated that PMM plasma levels are dose-dependent and that the PMM disposition-phase half-life is prolonged in patients with abnormal liver function."2.65Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies. ( Harrap, KR; Muindi, JR; Newell, DR; Smith, IE, 1983)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Joss, RA1
Brunner, KW1
Goldhirsch, A1
Oldham, DS1
Wampler, GL1
Muindi, JR1
Newell, DR1
Smith, IE1
Harrap, KR1

Trials

1 trial available for altretamine and Liver Neoplasms

ArticleYear
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.
    British journal of cancer, 1983, Volume: 47, Issue:1

    Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Kinetics;

1983

Other Studies

2 other studies available for altretamine and Liver Neoplasms

ArticleYear
Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
    Cancer treatment reports, 1982, Volume: 66, Issue:10

    Topics: Altretamine; Antineoplastic Agents; Carcinoma, Small Cell; Drug Therapy, Combination; Humans; Leukoc

1982
Hexamethylmelamine in adenocarcinoma of the pancreas and liver.
    Medical and pediatric oncology, 1983, Volume: 11, Issue:4

    Topics: Adenocarcinoma; Altretamine; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middl

1983